Sigma Healthcare OCF Margin
The Operating Cash Flow Margin of Sigma Healthcare (SIG.AX) as of Jul 25, 2026 is 9.98 %. In the previous year, Operating Cash Flow Margin was -6.41 % — a change of -255.73% (higher).
Get this data via API
Financial Data API
OCF Margin
9.98 %
YoY
-255.73%
Last updated:
Operating Cash Flow Margin of Sigma Healthcare is 2026 9.98 % . Operating Cash Flow Margin of Sigma Healthcare was 2025 -6.41 % . It decreases by -255.73% higher compared to the previous year.
Access this data via the Eulerpool API
Sigma Healthcare Stock analysis
What does Sigma Healthcare do? Sigma Healthcare Ltd is an Australian company that has been operating in the healthcare industry for over 100 years. Founded in 1911 as a local pharmacy in Melbourne, the company has since become a leading provider of pharmaceutical services in Australia.
The company's core business is the delivery of pharmacy products and services to pharmacies and medical practices across Australia. Sigma Healthcare Ltd supplies over 4,000 independent retailers as well as numerous large chains and department store pharmacies.
Sigma Healthcare Ltd also offers various healthcare services, such as consulting, training, and support in medication delivery.
Divided into different divisions, Sigma Healthcare Ltd offers a wide portfolio of products. In the pharmaceutical products division, the company distributes national and international medications, both prescription and over-the-counter. Additionally, health and personal care products such as medical devices, supplements, vitamins, and minerals are available.
The general products division offers a variety of non-food products, such as personal care products, wellness products, hygiene products, cleaning agents, cosmetics, and household products.
Another important division is the pharmacy management system, which supports pharmacies in managing their business and billing processes. The system complements the existing offering with additional features, such as inventory management, prescription processing, accounting, and customer loyalty.
Innovation plays a central role at Sigma Healthcare Ltd. The company invests significant resources in researching and developing new products and services to continuously improve the customer experience and meet the ever-growing demands of the industry. The company benefits from close relationships with leading manufacturers and international organizations.
Partnerships are another crucial aspect of Sigma Healthcare Ltd's business model. The company works closely with manufacturers, retailers, pharmacists, and other partners to jointly create innovative solutions and products to enhance the customer experience.
In recent years, Sigma Healthcare Ltd has also pursued a significant growth strategy, such as acquiring companies that complement its existing portfolio. This includes the acquisition of API in 2020 and Discount Drug Stores in 2018, which have greatly expanded the offerings of Sigma Healthcare Ltd.
Overall, Sigma Healthcare Ltd is an important company in the Australian healthcare industry. With a wide range of products and services, a strong culture of innovation, and significant partnerships with industry players, the company will continue to establish itself as a key player in healthcare and continuously improve the customer experience. Sigma Healthcare is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Sigma Healthcare stock
Operating Cash Flow Margin of Sigma Healthcare is 9.98 % in 2026.
Access this data via the Eulerpool API
Margins — Sigma Healthcare
All Key Metrics — Sigma Healthcare
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth